Search

Your search keyword '"Circulating DNA"' showing total 942 results

Search Constraints

Start Over You searched for: Descriptor "Circulating DNA" Remove constraint Descriptor: "Circulating DNA"
942 results on '"Circulating DNA"'

Search Results

1. Overview of the Role of Liquid Biopsy in Non-small Cell Lung Cancer (NSCLC).

2. IL‐1β/DNA complex elevation distinguishes autoinflammatory disorders from autoimmune and infectious diseases.

3. A systematic review on the applicability of cell‐free DNA level as an obesity biomarker.

4. Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer.

5. ctDNA as a predictor of outcome after curative resection for locally advanced rectal cancer: systematic review and meta‐analysis.

6. Case report: Microsatellite instability determination is not always black and white in Lynch syndrome diagnosis.

7. Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of patients with stage III colon cancerResearch in context

8. Prostate cancer and liquid biopsies: Clinical applications and challenges.

10. NETosis creates a link between diabetes and Long COVID.

11. Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer

12. Case report: Microsatellite instability determination is not always black and white in Lynch syndrome diagnosis

15. Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real‐world precision‐medicine population

16. Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial

18. Blood Plasma Circulating DNA-Protein Complexes: Involvement in Carcinogenesis and Prospects for Liquid Biopsy of Breast Cancer.

19. Molecular and cellular pathophysiology of circulating cardiomyocyte-specific cell free DNA (cfDNA): Biomarkers of heart failure and potential therapeutic targets

20. What is the role of the neutrophil extracellular traps in the cardiovascular disease burden associated with hemodialysis bioincompatibility?

21. Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real‐world precision‐medicine population.

22. Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial.

23. Neutrophil extracellular traps have auto-catabolic activity and produce mononucleosome-associated circulating DNA

24. Methods for the detection of tumor-specific single nucleotide somatic mutations in plasma cDNA samples

25. Comparison of the structures and topologies of plasma extracted circulating nuclear and mitochondrial cell-free DNA.

26. Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study.

27. Comparative Analysis of Molecular Functions and Biological Role of Proteins from Cell-Free DNA-Protein Complexes Circulating in Plasma of Healthy Females and Breast Cancer Patients.

28. Comparison of the structures and topologies of plasma extracted circulating nuclear and mitochondrial cell-free DNA

29. Predicting Response to Radical Chemoradiotherapy with Circulating HPV DNA (cHPV-DNA) in Locally Advanced Uterine Cervix Cancer.

30. A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms.

31. Persistence of neutrophil extracellular traps and anticardiolipin auto‐antibodies in post‐acute phase COVID‐19 patients.

32. Diagnosis and Staging

33. Circulating DNA fragmentomics and cancer screening

34. Neutrophil extracellular traps have auto-catabolic activity and produce mononucleosome-associated circulating DNA.

35. Clinical Applications of Liquid Biopsy in Colorectal Cancer Screening: Current Challenges and Future Perspectives.

36. Cell-free circulating tumor DNA in colorectal cancer: a proof of concept with simplified methodology.

39. Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer.

40. Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial.

41. Size and Methylation Index of Cell-Free and Cell-Surface-Bound DNA in Blood of Breast Cancer Patients in the Contest of Liquid Biopsy.

42. The Influence of Proteins on Fate and Biological Role of Circulating DNA.

43. Circulating Cell-Free Mitochondrial DNA in Pregnancy.

44. Monitoring levels of circulating cell‐free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment

45. Characterizing circulating nucleosomes in the plasma of dogs with lymphoma

46. Measuring Radiation Toxicity Using Circulating Cell-Free DNA in Prostate Cancer Patients

47. Evaluation of cell‐free DNA accuracy as diagnostic biomarker for prostate cancer: A systematic review and meta‐analysis.

48. Blood Plasma Exosomes Contain Circulating DNA in Their Crown.

50. Detection of Schistosoma mansoni DNA using polymerase chain reaction from serum and dried blood spot card samples of an adult population in North-western Tanzania

Catalog

Books, media, physical & digital resources